This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Guangzhou Virotech Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ziqing Lin: Innovator in Pharmaceutical Research
Introduction
Ziqing Lin is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of viral treatments. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Ziqing Lin holds a patent for the invention titled "M1 Virus Mutant and Use Thereof." This patent represents a breakthrough in the understanding and treatment of viral infections. It highlights his commitment to finding effective solutions in the pharmaceutical industry.
Career Highlights
Ziqing Lin is currently employed at Guangzhou Virotech Pharmaceutical Co., Ltd. His role at the company allows him to apply his knowledge and skills in a practical setting, contributing to the development of new therapies and treatments. His work is characterized by a focus on innovation and the application of scientific research to real-world problems.
Collaborations
Ziqing Lin collaborates with talented individuals in his field, including Yuan Lin and Guangmei Yan. These partnerships enhance the research and development process, fostering an environment of creativity and shared knowledge.
Conclusion
Ziqing Lin is a prominent figure in pharmaceutical innovation, with a patent that underscores his contributions to viral research. His work at Guangzhou Virotech Pharmaceutical Co., Ltd. and collaborations with colleagues further exemplify his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile